SEC Form 4 · accession 0001209191-17-031197
Kite Pharma, Inc. · KITE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paul L Jenkinson
Officer — Chief Financial Officer
Period of report
May 10, 2017
Accepted (ET)
May 10, 2017 · 3:12 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001510580
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 10, 2017 | P | 450 | $72.57 | A | 7,480 | D | |
| Common StockF2 | May 10, 2017 | P | 3,000 | $72.59 | A | 3,000 | I | See footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes 430 shares acquired under the 2014 Employee Stock Purchase Plan on February 17, 2017.
- F2The shares are held by The Amended & Restated Paul and Monika Jenkinson Family Trust Dated July 25, 2012.